Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) - Wikidata - awgldk - TriplyDB

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

http://www.wikidata.org/entity/Q28508886

about

Receptor for advanced glycation end products and its involvement in inflammatory diseases In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products Damage associated molecular pattern molecules A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?Emerging roles for HMGB1 protein in immunity, inflammation, and cancer The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types The role of the receptor for advanced glycation end-products in a murine model of silicosis A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression NMR analysis of synthetic human serum albumin alpha-helix 28 identifies structural distortion upon amadori modification.Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.Large scale isolation and purification of soluble RAGE from lung tissue.RAGE signaling in inflammation and arterial aging.Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.The receptor for advanced glycation end products (RAGE) and the lung.High-mobility group box 1 and cancer.Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy.Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis.On the significance of new biochemical markers for the diagnosis of premature labour.Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgery Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange Clearance kinetics and matrix binding partners of the receptor for advanced glycation end products.The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic.Circulating S100A12 Levels Are Associated with Progression of Abdominal Aortic Calcification in Hemodialysis Patients sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study Mouse Specific Cleavage-Resistant RAGE Splice Variant.

P2860

57928979327625e6737e22d002e33d9217d0baae

P248

Q21285070-A079124C-12EC-4525-9BCC-08F423A0736B Q24337632-5660BC04-E280-4E85-B6C4-57A7C7F8ADC8 Q24338271-966A7AA7-AF0A-4E03-A05E-3808438FF4CD Q24564765-1505E4B0-21AD-4AEE-B372-AA963D566B24 Q26765351-16F5C296-EBF2-4BE4-A69E-5ECF8BC6C0E9 Q26774333-E9012A23-9554-4187-822B-B615889657A2 Q27015835-E8E04C1B-4F1A-4979-870F-027B957E0529 Q28085089-D23CB5A7-A4F5-4B49-995B-5E9A52D7787A Q28242907-41D754BB-7678-4D4F-AB71-DA8A84DF2C5C Q28276929-0287A36F-C43E-466C-B839-C3763A440A1A Q28394344-A868D76B-5291-4C87-881F-A6DB4555FDE6 Q28507626-34F95AFE-392A-4398-81CB-E83093040AC3 Q28566123-A0A6B203-D8BE-43C9-B147-F6CB00F719A0 Q28579300-E88345FE-6E5E-413B-A1A9-A2E9EA6A5ADC Q28590453-66012513-1B10-4545-91C7-143821EEB5C7 Q30350576-634F63B8-8108-4F16-B717-E990524D5197 Q30410928-54C93E61-D9AB-4ED4-8D5A-C810A688A65A Q30422075-8200B032-E7ED-487E-AE8A-31CCD470E281 Q30426453-47888A78-7693-42A7-83F5-56541B45F9AE Q33344161-7005072E-891C-494C-8930-7C23B82651A4 Q33346824-1E51FD09-79BF-409A-B1DD-87BB6A734F4F Q33389069-97A4ED28-2CCD-445F-B36E-8FFC0C4C9F21 Q33633330-A940CA19-B1CE-4874-A14B-EA8D09936FF0 Q33638306-78379F1F-B24D-4628-ACC4-58574103B2DD Q33890233-1A6C6384-7298-40C4-B778-BA1B7B095F48 Q34443979-9C8B68F1-D0ED-4613-B6B8-59109423F8F6 Q34531584-DC9AA46D-60B6-4F9C-A228-6F5E64396381 Q34762626-939345CA-E02B-403D-8522-615AC92BF3C3 Q34784921-6B09FC26-3B83-4A97-8328-A78E9AAFB1EB Q34875734-C8B3BEF9-C8F1-405C-AFFE-2903C9E31861 Q35009387-1E2F51BC-B995-4315-AE28-EE3F9A10C303 Q35124150-B5AA0993-A50B-4366-8E3F-C244EA71DE61 Q35621852-FD7F73FD-DCC6-4CD7-88AC-2064F51799DF Q35658848-76D66F8A-08A0-47B5-ACD2-A6E2B9023636 Q35746399-891E8283-1A31-4AA4-A24E-47C9D6167357 Q35752436-7F7BC652-676A-49C2-89F4-71F1FBCB2F74 Q35935760-E484D6E2-8A32-4AC0-9EB1-B5D14F9CDA23 Q36070548-461EEB92-85E9-47CB-B49D-2C5DEA83C692 Q36091982-FF8ABB89-5BF9-466F-B00F-3D18077CD1D6 Q36139535-29FD8DDA-8ECB-4936-9216-0CEF847E44BA

P2860

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

http://www.wikidata.org/entity/Q28508886

description

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 2004

@ast

im November 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2004/11/26)

@sk

vědecký článek publikovaný v roce 2004

@cs

wetenschappelijk artikel (gepubliceerd op 2004/11/26)

@nl

наукова стаття, опублікована в листопаді 2004

@uk

name

Purification and characterizat ...... glycation end products (sRAGE)

@ast

Purification and characterizat ...... glycation end products (sRAGE)

@en

Purification and characterizat ...... glycation end products (sRAGE)

@nl

type

label

Purification and characterizat ...... glycation end products (sRAGE)

@ast

Purification and characterizat ...... glycation end products (sRAGE)

@en

Purification and characterizat ...... glycation end products (sRAGE)

@nl

prefLabel

Purification and characterizat ...... glycation end products (sRAGE)

@ast

Purification and characterizat ...... glycation end products (sRAGE)

@en

Purification and characterizat ...... glycation end products (sRAGE)

@nl

P1433

Q28508886-C8ED04F5-2239-4324-BDC8-6A126B12E7BC

P1476

Q28508886-AC4FF367-8CE9-4B53-8F7C-8556853C899D

P2093

Q28508886-037D8A5E-670A-4D16-8E33-5DE9875A0378

Q28508886-2C216573-57AB-4467-A4AB-0920455A6F10

Q28508886-37CB35A2-29C6-4E6C-8B73-78DB50E4A451

Q28508886-A1D42F74-F95D-46DB-B450-6557CE679D6C

Q28508886-A4E6FE30-6B2B-42F7-800C-C4468675B497

Q28508886-A8306D1D-4FA6-4B97-BCC2-6C07D415EE55

Q28508886-C12DE261-566A-415E-94AE-08ECC387DA3E

P2860

Q28508886-01E12306-6039-4C69-A044-32B80F2FEF4B

Q28508886-0C1C582E-C543-43D6-B6F3-35B19FD3CDD2

Q28508886-3240B156-714D-4E58-9C50-F2DFF106AFCA

Q28508886-3248332E-0585-4E6C-8CBF-1EE1E904BDE7

Q28508886-3916B3A6-6FDC-4D45-8E76-3D68E100479F

Q28508886-3F9E111F-8756-456D-9A79-CFAFEAF0FA5C

Q28508886-5CF7D02B-EABF-4AB0-81AA-38D44FCBC592

Q28508886-64CA995C-DB79-4D53-9A12-3941B23EADAF

Q28508886-68C8E1E2-070A-4EA6-B1EC-3C3774E76CA9

Q28508886-6AD87B8A-426E-4ADE-AE17-5CCF1C9C908F

P304

Q28508886-64259A89-D00E-43F6-B121-646075E73F89

P31

Q28508886-2848C231-0C00-4D90-B049-BAEA8011A9A9

P3181

Q28508886-E1978441-8601-490E-B5C1-2299C362713D

P356

Q28508886-1D3F9098-78B0-4FD6-BFB8-652956103A0D

P407

Q28508886-5CB82F33-3FE2-48BF-9662-70E08625EBA4

P433

Q28508886-5A74765A-1DDE-4F82-A3D8-387A687C704F

P478

Q28508886-AB80C1C5-3C1C-4FEC-B817-28865D8FB01D

P50

Q28508886-353AD95D-DA6D-4DA2-99B1-443FF13E5AD7

P577

Q28508886-C786B7AF-D5F2-4B12-8FB5-A74ECAFF40B9

P5875

Q28508886-51E0F2CC-7428-4C3A-B9AA-404C1C5539BC

P698

Q28508886-90766419-6DA1-4947-8487-EE33C671CF18

P932

Q28508886-0CE97B5D-3202-4A1F-8834-C00453F292BE

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Purification and characterizat ...... glycation end products (sRAGE)

@en

P2093

Lana E Hanford

http://www.w3.org/2001/XMLSchema#string

Lisa M Schaefer

http://www.w3.org/2001/XMLSchema#string

Steen V Petersen

http://www.w3.org/2001/XMLSchema#string

Tim D Oury

http://www.w3.org/2001/XMLSchema#string

Todd A Reinhart

http://www.w3.org/2001/XMLSchema#string

Todd M Schaefer

http://www.w3.org/2001/XMLSchema#string

Zuzana Valnickova

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Probability-based protein identification by searching sequence databases using mass spectrometry data

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

P304

50019-50024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3419164

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M409782200

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8332669

http://www.w3.org/2001/XMLSchema#string

P698

15381690

http://www.w3.org/2001/XMLSchema#string

P932

1868562

http://www.w3.org/2001/XMLSchema#string